Clinical Trials Browser

Phase 2 × Unknown × tipifarnib × Clear all

NCT02535650 2022-03-08

Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT00510939 2009-08-14

HEMOS AML 0106

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute